WASHINGTON (Reuters) - Cholesterol-lowering drugs do not raise or lower the risk of cancer, researchers said on Tuesday in two new reports that challenge earlier findings suggesting statins may prevent certain cancers.
Researchers at the University of Connecticut analyzed 26 previous studies involving 87,000 total patients, but concluded the blockbuster drugs had no cancer impact, according to their report published in the Journal of the American Medical Association.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!